1. Home
  2. Analysis
  3. Hydroxyzine-hydrochloride
  4. Aldactazide

Hydroxyzine hydrochloride and Aldactazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 2 people who take Hydroxyzine hydrochloride and Aldactazide. Common interactions include chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Hydroxyzine hydrochloride and Aldactazide have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2023

2 people who take Hydroxyzine hydrochloride and Aldactazide together, and have interactions are studied.

What is Hydroxyzine hydrochloride?

Hydroxyzine hydrochloride has active ingredients of hydroxyzine hydrochloride. It is used in stress and anxiety. Currently, eHealthMe is studying from 8,479 Hydroxyzine hydrochloride users.

What is Aldactazide?

Aldactazide has active ingredients of hydrochlorothiazide; spironolactone. It is used in high blood pressure. Currently, eHealthMe is studying from 1,579 Aldactazide users.

Number of Hydroxyzine hydrochloride and Aldactazide reports submitted per year:

Hydroxyzine hydrochloride and Aldactazide drug interactions.

Common Hydroxyzine Hydrochloride and Aldactazide drug interactions by gender *:

female:

n/a

male:

  1. Chronic kidney disease
  2. Renal cyst
  3. Hypokalaemia
  4. Intermittent claudication
  5. Renal impairment
  6. Staphylococcal infection
  7. Renal failure
  8. Angina pectoris
  9. Benign prostatic hyperplasia
  10. Constipation

Common Hydroxyzine Hydrochloride and Aldactazide drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal cyst
  3. Hypokalaemia
  4. Intermittent claudication
  5. Renal impairment
  6. Staphylococcal infection
  7. Renal failure
  8. Angina pectoris
  9. Benign prostatic hyperplasia
  10. Constipation

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyzine hydrochloride and Aldactazide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Hydroxyzine hydrochloride drug interactions:

Browse interactions between Hydroxyzine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aldactazide drug interactions:

Browse interactions between Aldactazide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyzine hydrochloride and hydrochlorothiazide; spironolactone (the active ingredients of Hydroxyzine hydrochloride and Aldactazide, respectively), and Hydroxyzine hydrochloride and Aldactazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Hydroxyzine hydrochloride and Aldactazide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.